Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03375918 · ClinicalTrials.gov registry record · NA

COmmuNity-engaged SimULation Training for Blood Pressure Control

A NA study, sponsored by University of Massachusetts, Worcester.

Completed
Registry status
NA
Development phase
118
Enrollment target

NCT03375918: Completed NA study, sponsored by University of Massachusetts, Worcester.

NCT03375918 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 118 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03375918, a NA study, has completed, sponsored by University of Massachusetts, Worcester.

COMPLETED
Registry status
NA
Development phase
118 participants
Enrollment target

Study Summary

The goal of CONSULT-BP is to train early-stage healthcare providers, including residents and nurse practitioner (NP) students, to mitigate providers' bias, improve communication skills, and enhance providers' ability to develop authentic and meaningful therapeutic alliances with patients. The study setting is an academic safety net hospital that serves a large non-White and poor population. The Investigators hypothesize that patients' outcomes (blood pressure levels) will be lower after the training intervention compared with before training (control) periods.

Primary Outcome

Systolic and diastolic blood pressure of patients treated by the participating clinician trainees as reported in the Electronic Medical Record.

Interventions

  • OTHER CONSULT-BP Educational Intervention

Trial Details

FieldValue
Enrollment Target 118 participants
Start Date 2018-08-13
Est. Completion 2024-01-31
Phase NA

What the finished NCT03375918 record still lists

NCT03375918 is an interventional study that assigns participants to a tested intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 1 intervention - of which CONSULT-BP Educational Intervention is the first listed.

NCT03375918 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03375918 about?

NCT03375918 is a clinical study titled "COmmuNity-engaged SimULation Training for Blood Pressure Control". The goal of CONSULT-BP is to train early-stage healthcare providers, including residents and nurse practitioner (NP) students, to mitigate providers' bias, improve communication skills, and enhance providers' ability to develop authentic and meaningful therapeutic alliances with patients. The study ...

What is the current status of trial NCT03375918?

This trial is currently completed. It is a NA study. The enrollment target is 118 participants. The study started on 2018-08-13. Estimated completion is 2024-01-31.

What interventions are being tested in trial NCT03375918?

The interventions under investigation include: CONSULT-BP Educational Intervention (OTHER).

Who is sponsoring clinical trial NCT03375918?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03375918's enrollment target sits among peer trials

118 803rd of 2000 higher than 1,194 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03821623 · 118 participants · Phase 2

    Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults

  • NCT04040959 · 118 participants · Phase 2

    Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD

  • NCT04696029 · 118 participants · Phase 2

    DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

  • NCT05223192 · 118 participants · NA

    The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03375918, the US trial registry maintained by the National Library of Medicine. NCT03375918 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.